Fluorofenidone Attenuates Tubulointerstitial Fibrosis by Inhibiting TGF-β1-Induced Fibroblast Activation

Qiongjing Yuan, Rui Wang, Yu Peng, Xiao Fu, Wei Wang, Linghao Wang, Fangfang Zhang, Zhangzhe Peng, Gaoyun Hu, Zhaohe Wang,

American Journal of Nephrology · 2011 · 32 citations · 46 references

Abstract

AKF-PD treatment inhibits the progression of renal interstitial fibrosis in obstructed kidneys; this is potentially achieved by suppressing fibroblast activation. Therefore, AKF-PD is a special candidate for the treatment of renal fibrosis.

References

46